Veterinary Pain Management Market is expected to grow from USD 2 billion in 2022 to USD 3.43 billion by 2030 : GreyViews

Veterinary Pain Management Market Size by Product (NSAIDs and Anesthetics), By Indication (Osteoarthritis and Joint Pain, Postoperative Pain, Cancer, and Other Applications), By Animal Type (Companion and Livestock), By End Use (Hospitals and Clinics), Regions, Segmentation, and forecast till 2030.


Pune India, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the veterinary pain management market is operating and is predicted to expand soon. The manufacturers and suppliers involved in the veterinary pain management market are present across various countries in the above-mentioned regions.

Get Sample Copy of This Report @ https://greyviews.com/reports/veterinary-pain-management-market/390/request-sample

The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as the product, indication, animal type and regions. Apart from this, the key driving factors, restraints, potential growth opportunities and market challenges are also discussed in the below paragraphs.
The significant players operating in the global veterinary pain management market are IDEXX Laboratories, Elanco, Bayer AG, Virbac, Ceva, Dechra Pharmaceuticals, Assisi Animal Health, Merck Sharp & Dohme Corp, BoehringerIngelheim International GmbH, Norbrook, Zoetis, Vetoquinol among others. To achieve a substantial market share in the worldwide veterinary pain management market and strengthen their position, manufacturers are pursuing expansion methods such as current developments, mergers and acquisitions, product innovations, collaborations, and partnerships, joint ventures.
There are many large, small, and exotic animal species covered in Pain Management in Veterinary Practice, which offers veterinary practitioners the information needed to recognize and manage their pain. An in-depth look at the physiology and pathophysiology of pain, including acute, adaptive, chronic, and maladaptive pain. The practice of pain management provides veterinarians with the knowledge necessary to detect and manage pain in a variety of animals. To provide compassionate care to dogs and cats, pain control is one of the most important aspects of veterinary medicine. Government organizations are expected to increase initiatives to promote animal health globally, which will drive market growth. For example, a report by the European External Action Service shows that the European government spent USD 4.7 million on animal healthcare in 2016. A rapid evolution of digital monitoring and surveillance is rapidly transforming the animal health landscape, improving efficiency and speed. Digital technologies are transforming animal health through products like smart tags, sensors, remote monitoring surveillance, and smart building designs. The market growth is driven by various factors such as rising awareness about animal healthcare, increased R&D etc., but there are some factors which are hampering the growth of the market such as side-effects associated with the medications, high cost, lack of awareness about animal health etc.

Enquiry Before Buying This Report @ https://greyviews.com/inquiry/390

Scope of Veterinary Pain Management Market Report:

Report MetricInformation
Study Period2022-2030
Base Year           2022
Forecast Period2023-2030
Market Share UnitUSD Billion
Segments CoveredProduct, Indication, Animal Type,End-User, and Regions.
Regions CoveredNorth America, Europe, Asia-Pacific, South America, and Middle-East and Africa
Major PlayersIDEXX Laboratories, Elanco, Bayer AG, Virbac, Ceva, Dechra Pharmaceuticals, Assisi Animal Health, Merck Sharp & Dohme Corp, BoehringerIngelheim International GmbH, Norbrook, Zoetis, Vetoquinol among others

Segmentation Analysis

NSAIDs is expected to be the fastest-growing segment in 2022. 

The product segment includes NSAIDs and Anesthetics. The NSAIDs segment is expected to witness the highest growth rate during the forecast period. New NSAIDs are being developed by businesses in an effort to reduce side effects and response to osteoarthritis-related pain and inflammation. These are the drugs which are most commonly used to treat osteoarthritis-related pain and inflammation. Moreover, strict regulations regarding the use of opioids are expected to boost the market over the forecasted period.

Osteoarthritis is expected to be the fastest-growing segment in 2022. 

The Indication segment includes osteoarthritis and joint pain, postoperative pain, cancer, and other applications. The osteoarthritis segment is expected to witness the highest growth rate during the forecast period. It is estimated that 14.7 million dogs in the United States suffer from osteoarthritis. The treatment of mild pain with nutraceuticals is recommended. Moderate to severe pain can be treated with NSAIDs and coxoids.

Livestock is expected to be the fastest-growing segment in 2022. 

The animal type segment includes companions and livestock. The livestock segment is expected to witness the highest growth rate during the forecast period. Since chronic diseases are on the rise, animal healthcare groups are becoming more aware of them, and emerging nations are spending a lot on animal healthcare, livestock animals are experiencing visual signs of discomfort, such as lameness, accelerated breathing, vocalization, and teeth grinding. All these issues are boosting the growth of the veterinary pain management market.

Regional Analysis           

The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the veterinary pain management market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia.

The North American region witnessed a major share. Due to the growing number of pet owners and the demand for effective animal care, the North American market is witnessing significant growth. Furthermore, the development is being further fueled by highly advanced and established animal healthcare facilities. The rising veterinary healthcare investment will add more value to the market growth in the future,

 Country Analysis

  • Germany

Germany's Veterinary Pain Management Market size was valued at USD 0.16 billion in 2022 and is expected to reach USD 0.24 billion by 2030, at a CAGR of 5.2% from 2023 to 2030.
There is an increase in corporate alliances, mergers, and acquisitions driving the market's expansion in Germany, as well as businesses, are introducing new products in order to deal with rising concerns for animal healthcare, which also fuels the market growth.

  • China

China veterinary pain management’s market size was valued at USD 0.24 billion in 2022 and is expected to reach USD 0.38 billion by 2030, at a CAGR of 6.2% from 2023 to 2030.
Partnerships between the public and private sectors and strategic collaborations towards the adoption and implementation of new and improved technology are opening up attractive market prospects which will boost the growth of the veterinary pain management market in the country.

  • India

India's Veterinary Pain Management Market size was valued at USD 0.2 billion in 2022 and is expected to reach USD 0.31 billion by 2030, at a CAGR of 5.8% from 2023 to 2030.
Continuous research and development to improve the efficiency of medications used for veterinary pain management and rising awareness about the health of livestock animals in the country are boosting the growth of the market.
Covid-19 Impact
Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries.

Furthermore, the growth of this market is mainly driven owing to the increasing demand from the livestock segment, propelling the growth of the market across the countries.

Buy Now Full Report @ https://greyviews.com/checkout/390/single_user_license

Contact Us
Rocky Shah
GreyViews
Pune India
Phone: (+44) 162-237-1047
Email: sales@greyviews.com

Web: https://greyviews.com/

Follow Us: LinkedIn | Twitter

Browse Related Reports:

Veterinary Pain Management Market Size By Product (NSAIDs and Anesthetics), By Indication (Osteoarthritis and Joint Pain, Postoperative Pain, Cancer, and Other Applications), By Animal Type (Companion and Livestock), By End-User (Hospitals and Clinics), Regions, Segmentation, and Projection till 2030             

https://greyviews.com/reports/veterinary-pain-management-market/390

Varicose Vein Treatment Market Size By Type (Endovenous Ablation, Surgical Ligation & Stripping, and Sclerotherapy), By End-User (Vein Clinics, Ambulatory Care Unit, And Hospital), Regions, Segmentation, and Projection till 2030             

https://greyviews.com/reports/varicose-vein-treatment-market/389

Surgical Sutures Market Size By Type (Absorbable and Non absorbable), By Application (Ophthalmic Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, and Others), Regions, Segmentation, and Projection till 2030        

https://greyviews.com/reports/surgical-sutures-market/385

Surgical Equipment Market Size By Product (Electrosurgical Devices Sutures, Surgical Sutures, Handheld Devices, and Staplers), By Application (Orthopedics, Obstetrics and Gynecology, Neurology, Cardiovascular, Plastic and Reconstructive Surgeries, and Others), Regions, Segmentation, and Projection till 2030        

https://greyviews.com/reports/surgical-equipment-market/384

Psychedelic Drugs Market Size By Drug Type (Phencyclidine, Etamine, 3,4-MethylEnedioxyMethamphetamine (Ecstasy), Lysergic Acid Diethylamide (LSD), Gamma Hydroxybutyric Acid (GHB), Ayahuasca, Salvia, Psilocybin, and Others), By Patient Type (Resistant depression, Major Depressive Disorder, Post-traumatic stress disorder, Panic disorder, Narcolepsy, Opiate Addiction, and Others), Regions, Segmentation, and Projection till 2030      

https://greyviews.com/reports/psychedelic-drugs-market/379

Prostate Cancer Therapeutics Market Size By Drug Type (Chemotherapy, Targeted Therapy, Hormonal Therapy, Immunotherapy, and Others), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Drug Stores and Retail Pharmacies), Regions, Segmentation, and Projection till 2030 

https://greyviews.com/reports/prostate-cancer-therapeutics-market/378

Pregnancy Care Products Market Size By Product (Breast Cream, Stretch Mark Minimizer, Firming Lotion, Body Restructuring Gel and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Stores and Others), Regions, Segmentation, and Projection till 2030      

https://greyviews.com/reports/pregnancy-care-products-market/376

Medical Device Sterilization Market Size By Product (Reagents, Instruments, and Services), By End-User (Hospitals, Pharmaceutical Companies, Laboratories, Clinics, Medical Device Manufacturers, Academic and Research Institutes, and Others), Regions, Segmentation, and Projection till 2030     

https://greyviews.com/reports/medical-device-sterilization-market/373

Hemodynamic Monitoring System Market Size By System (Invasive Monitoring Systems, Minimally Invasive Monitoring Systems, and Non-invasive Monitoring Systems), By End-User (Catheterization Laboratories, Hospitals, and Others), Regions, Segmentation, and Projection till 2030  

https://greyviews.com/reports/hemodynamic-monitoring-system-market/372

Dermatology Lasers Market Size By Type (Gem Laser Machine, Gas Laser Machine, and Semiconductor Laser Machine), By Application (Beauty and Skin Diseases), Regions, Segmentation, and Projection till 2030  

https://greyviews.com/reports/dermatology-lasers-market/370